Medisafe Presents Results of Study on Chronically Non-Adherent Patients
Summary
NEW ORLEANS, May 21, 2019 /PRNewswire/ -- Medisafe, the personalized medication management platform with over five million users worldwide, announced today that further findings from its ongoing scientific study conducted by IQVIA will be presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 24th Annual International Meeting in New Orleans, LA. The meeting draws more than 4,000 health economics and outcomes research (HEOR) thought leaders and stakeholders from over 70 countries and is one of the worlds largest conferences for pharmacoeconomic and outcomes research. The latest study findings showed clinically and statistically meaningful results across two standard healthcare industry adherence metrics: Hypertension, diabetes and depression patients increased their mean MPR from below 0.6 before using Medisafe ("pre-app") to above 0.9 after using Medisafe ("post-app"). Additionally, almost 70% of non-adherent patients (MPR
Classifications
AskAI Classifications
LabelsLinked Companies
